Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, July 5, 2022.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)
Crossroads (+60) - ABOS is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid ABOS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABOS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABOS
The long-term trend has been DOWN since Jul 16th, 2021 at 16.9275
The intermediate-term trend has been UP since Jun 27th, 2022 at 4.0600
The short-term trend has been UP since Jun 22nd, 2022 at 3.5200
Smart Scan Analysis for ABOS
Based on our trend formula, ABOS is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 4.7100 | 5.0225 | 4.4014 | 4.7000 | 0.0000 |
| Prev. Close | Volume | Bid | Ask | Time |
| 4.7100 | 107294 | 2022-07-01 15:59:38 |
| 52wk High | 20.99 | 52wk High Date | 2021-07-02 |
| 52wk Low | 3.02 | 52wk Low Date | 2022-05-12 |
| Average Volume | 362,916 | Shares Outstanding | 40,501 |
| Assets | 220,087,000M | Liabilities | 3,998,000M |